Immunocore Holdings (IMCR) Leases: 2022-2025
Historic Leases for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $39.4 million.
- Immunocore Holdings' Leases fell 0.69% to $39.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 million, marking a year-over-year decrease of 0.69%. This contributed to the annual value of $37.6 million for FY2024, which is 12.30% up from last year.
- Per Immunocore Holdings' latest filing, its Leases stood at $39.4 million for Q3 2025, which was down 0.08% from $39.4 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Leases ranged from a high of $39.7 million in Q3 2024 and a low of $30.9 million during Q4 2022.
- In the last 3 years, Immunocore Holdings' Leases had a median value of $37.9 million in 2024 and averaged $36.6 million.
- The largest annual percentage gain for Immunocore Holdings' Leases in the last 5 years was 21.56% (2025), contrasted with its biggest fall of 0.69% (2025).
- Over the past 4 years, Immunocore Holdings' Leases (Quarterly) stood at $30.9 million in 2022, then grew by 8.32% to $33.5 million in 2023, then increased by 12.30% to $37.6 million in 2024, then decreased by 0.69% to $39.4 million in 2025.
- Its Leases was $39.4 million in Q3 2025, compared to $39.4 million in Q2 2025 and $38.1 million in Q1 2025.